KOC
CVS icon

Koss-Olinger Consulting’s CVS Health CVS Stock Holding History

Koss-Olinger Consulting’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,537
Closed -$398K – 193
2026
Q1 		$398K Sell
5,537
-275
-5% -$21.2K 0.03% 175
2025
Q4 		$461K Sell
5,812
-1,608
-22% -$127K 0.04% 173
2025
Q3 		$512K Hold
7,420
– – 0.04% 202
2025
Q2 		$512K Sell
7,420
-548
-7% -$35.9K 0.04% 202
2025
Q1 		$540K Sell
7,968
-20,751
-72% -$1.24M 0.05% 184
2024
Q4 		$1.29M Sell
28,719
-6,165
-18% -$346K 0.11% 86
2024
Q3 		$2.19M Sell
34,884
-2,141
-6% -$125K 0.19% 72
2024
Q2 		$2.19M Buy
+37,025
New +$2.32M 0.2% 64
2024
Q1 		– Sell
-22,603
Closed -$1.78M – 106
2023
Q4 		$1.78M Buy
22,603
+7,465
+49% +$531K 0.18% 63
2023
Q3 		$1.06M Buy
15,138
+6,658
+79% +$472K 0.16% 83
2023
Q2 		$586K Buy
8,480
+50
+0.6% +$3.56K 0.07% 124
2023
Q1 		$626K Buy
8,430
+114
+1% +$9.56K 0.08% 116
2022
Q4 		$775K Sell
8,316
-1,762
-17% -$170K 0.11% 93
2022
Q3 		$961K Sell
10,078
-511
-5% -$50.6K 0.16% 55
2022
Q2 		$981K Sell
10,589
-2,893
-21% -$282K 0.18% 50
2022
Q1 		$1.36M Sell
13,482
-967
-7% -$102K 0.22% 38
2021
Q4 		$1.49M Sell
14,449
-4,334
-23% -$400K 0.23% 34
2021
Q3 		$1.59M Sell
18,783
-6,230
-25% -$522K 0.26% 31
2021
Q2 		$2.09M Buy
25,013
+728
+3% +$59.6K 0.31% 34
2021
Q1 		$1.83M Buy
+24,285
New +$1.77M 0.31% 35

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Koss-Olinger Consulting's CVS Position: Q2 2026 in Review

Koss-Olinger Consulting sold out of CVS Health (CVS) in Q2 2026, closing a stake of 5,537 shares — an estimated $398K sold.

Koss-Olinger Consulting first reported a position in CVS in Q1 2021 and held it in 20 quarters. The position peaked at $2.19M in Q3 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Koss-Olinger Consulting reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • Koss-Olinger Consulting sold 5,537 CVS Health shares in Q2 2026, an estimated $398K.
  • Koss-Olinger Consulting first reported a position in CVS Health in Q1 2021 and held it in 20 quarters.
  • Koss-Olinger Consulting's CVS Health position peaked at $2.19M in Q3 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Koss-Olinger Consulting's 13F filing for Q2 2026, filed 10 Aug 2026.